Page last updated: 2024-09-05

deferasirox and senicapoc

deferasirox has been researched along with senicapoc in 1 studies

Compound Research Comparison

Studies
(deferasirox)
Trials
(deferasirox)
Recent Studies (post-2010)
(deferasirox)
Studies
(senicapoc)
Trials
(senicapoc)
Recent Studies (post-2010) (senicapoc)
83213657242332

Protein Interaction Comparison

ProteinTaxonomydeferasirox (IC50)senicapoc (IC50)
Intermediate conductance calcium-activated potassium channel protein 4Homo sapiens (human)0.009

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okpala, I1

Reviews

1 review(s) available for deferasirox and senicapoc

ArticleYear
Investigational agents for sickle cell disease.
    Expert opinion on investigational drugs, 2006, Volume: 15, Issue:8

    Topics: Acetamides; Anemia, Sickle Cell; Animals; Antihypertensive Agents; Antisickling Agents; Benzaldehydes; Benzoates; Carnitine; Cell Adhesion; Deferasirox; Endothelium, Vascular; Etilefrine; Female; Genetic Therapy; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Hypertension, Pulmonary; Iron Chelating Agents; Male; Membrane Glycoproteins; Potassium Channels, Calcium-Activated; Priapism; Recombinant Fusion Proteins; Triazoles; Trityl Compounds; Vasoconstrictor Agents

2006